The effect of oral use of Mentha Longifolia capsule on the symptoms of premenstrual and the severity and duration of menstrual pai

Phase 3

Recruiting

Conditions: Condition 1: primary dysmenorrhea. Condition 2: Premenstrual syndrome.
Primary Dysmenorrhea
Pain localized to other parts of lower abdomen
N94.4
R10.3

Registration Number: IRCT20210630051749N1

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 64

Inclusion Criteria

Be Iranian and single.
Be a resident of the dormitories of Mashhad University of Medical Sciences.
Have regular menstruation
Have premenstrual syndrome and primary dysmenorrhea at the same time.
Be 18-35 years old.
No medication
No allergies to mint
No alcohol or drugs or tobacco
No diet
No disease

Exclusion Criteria

Discontinuation of medication or irregular use of medication (not taking medication twice or more)
Have a BMI of more than 30.
Be a professional athlete.
Suffer from depression, stress and anxiety .
Experience an unfortunate or stressful event while studying.
Has used traditional medicine methods to reduce symptoms and improve pain.
Married while studying.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean score of total premenstrual syndrome symptoms, severity and duration of dysmenorrhea. Timepoint: Mean score of total symptoms of premenstrual syndrome, severity and duration of dysmenorrhea at the beginning of the study (before the intervention) and 1 and 2 months after the intervention. Method of measurement: The mean total score of premenstrual syndrome symptoms will be assessed by COPE premenstrual events calendar form and the severity and duration of dysmenorrhea in the first and second months of the treatment cycle, by visual pain scale and COX scale and by patients' self-report.

Secondary Outcome Measures